SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending as community sentiment balances between bullish technical setups and cautious skepticism regarding its long-term utility. Traders are actively debating potential breakout levels while watching for broader market momentum to influence the coin's next move.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing heightened trading volume and speculative momentum as investors rotate into Japanese blockchain projects and IoT-focused tokens. While community members are polarized between long-term accumulation and skepticism regarding project leadership and ecosystem expansion, active discussions remain centered on potential technical breakout patterns and broader data economy narratives.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MullenArmy community is actively attempting to revitalize interest in their crypto token, frequently citing its past market cap highs and the potential for a new parabolic rally. While proponents encourage buyers to hold through volatility and rotate profits from other assets, skeptics continue to warn of historical pump-and-dump patterns and the token's lack of fundamental utility.

Fartcoin is a meme-driven cryptocurrency where users can submit their best fart jokes or memes to earn initial tokens. Each transaction triggers a hilarious 'Gas Fee' effect, complete with a digital fart sound for maximum comedic impact.

Fartcoin

Fartcoin is seeing increased community engagement as traders speculate on its price trajectory and potential for a breakout, often drawing comparisons to other speculative assets. The conversation is heavily driven by its active social media presence, with proponents highlighting its status as a meme coin and its frequent inclusion in broader crypto trend discussions.

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

TransCode Therapeutics Inc

TransCode Therapeutics is currently seeing intense activity following a strategic acquisition of Polynoma and a significant equity infusion, which investors are weighing against concerns regarding dilution and the company's past history of reverse splits. Community discussion is heavily focused on whether this financing provides the necessary runway for their metastatic cancer drug, TTX-MC138, to finally demonstrate efficacy in upcoming Phase 2 trials.

$ORDI : first token deployed on Bitcoin Ordinals, with a 21 million supply. $DOGI : first token deployed on Dogecoin Ordinals, with a 21 million supply. The First DRC-20 token in the history

dogi

DOGI is gaining momentum as the first DRC-20 token on the Dogecoin network, with community members actively accumulating the asset alongside Dogecoin. Traders are highlighting the upcoming launch of Doge OS and rising transaction volumes as key catalysts driving sentiment around the project's utility and market potential.

BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).   The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.  The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.

Bio Protocol

Bio Protocol is capturing attention following its recent listing on Coinbase and excitement surrounding its V2 upgrade, which includes new staking rewards. Community sentiment is highly bullish as investors draw comparisons to other high-momentum tokens, actively debating potential price breakouts and the long-term potential of the DeSci sector.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy is trending as the community debates its long-term potential and utility amidst a challenging price environment. While some investors express frustration over recent performance, others are actively accumulating tokens, holding onto the belief that the project will eventually see a significant recovery.

A community-driven memecoin created to protect and empower crypto users, CTOs, and low-marketcap gems. Our ecosystem features weekly crypto talks/hosting services, a “Most Wanted" scam tracker, and a "Portfolio" with partnered projects. We help others succeed through long-term partnerships and services.   Weekly Hosting: a weekly hosting service where the team and community come together to talk about crypto and project updates. We will invite guests from rugged projects who want to talk/share insight, invite CTO/low market cap projects to come speak about what they are doing, and give dedicated time for partnered projects to speak on updates for our listeners.   Portfolio: webpage highlighting CTOs, low market cap gems, and strong founding teams. Projects must meet internal standards: long-term vision, accountable/transparent  leadership, real utility or original design, fair incentives, and consistent execution.  Commitment Mechanism: Projects signal alignment with $RCON’s values by voluntarily burning $RCON, demonstrating long-term conviction and shared responsibility. The Marketcap of $RCON dictates burn tiers for each new project.  &lt; 250k Marketcap - variable at team discretion 250k - 500k Marketcap - $1,000 USD 500k - 1M Marketcap - $1,500 USD 1M - 2.5M Marketcap - $2,000 USD 2.5M - 5M Marketcap - $3,000 USD 5M - 10M Marketcap - $4,000 USD 10M+ Marketcap - $5,000 USD  Most Wanted: A webpage highlighting community-reported concerns, risk indicators, and educational insights related to suspected scams, exploits, or high-risk crypto activity. Content is aggregated from public posts using hashtag #RRMW (Recon Raccoon’s Most Wanted) on X and reflects community observations and opinions for informational purposes only. Inclusion does not imply wrongdoing. Users should independently verify all information.

Recon Raccoon

Recon Raccoon is gaining traction behind a series of exchange listings and ongoing marketing campaigns designed to expand its visibility within the Solana ecosystem. The community is actively discussing the project's long-term infrastructure, including new liquidity pools and strategic partnerships intended to drive sustainable growth.

Brinker International, Inc. engages in owning, developing, and franchising Chili's Grill and Bar and Maggiano's Little Italy restaurant brands. It operates through the Chili's and Maggiano's segments. The Chili's segment includes the results of company-owned Chili's restaurants in the U.S. and Canada as well as the results from its domestic and international franchise business. The Maggiano's segment refers to the results of company owned Maggiano's restaurants. The company was founded by Larry Lavine on March 13, 1975 and is headquartered in Dallas, TX.

Brinker International, Inc.

Brinker International, Inc. (EAT) has emerged as a standout performer in the restaurant sector, with investors pointing to robust same-store sales growth, traffic gains at Chili's, and successful menu innovation as key drivers behind the stock's recent momentum. The community is actively discussing the company's operational execution and its ability to maintain value-oriented appeal, though some participants remain cautious, debating the sustainability of current valuation levels and potential macro headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should SNDL Stock Be in Your Portfolio Post Q1 Earnings?

SNDL faces pressure after Q1 results show falling sales, weak cannabis demand, and margin strain, raising concerns about growth in a saturated Canadian market.

Aurora Cannabis (NASDAQ:ACB) Stock Price Up 0.6% - Here's Why

Aurora Cannabis (NASDAQ:ACB) Trading 0.6% Higher - What's Next...

<ul class="summary-bullets"><li>AKAN is also on track for its best week ever with gains of 300% so far.</li><li>Investor sentiment across cannabis stocks improved after the U.S. Justice Department moved state-regulated marijuana toward Schedule III.</li><li>AKAN’s rally was amplified by its tiny public float of about 534,420 shares, following multiple reverse stock splits.</li></ul>Shares of Akanda Corp. (AKAN) delivered one of the biggest rallies in April among cannabis stocks, rocketing 1,700% and sharply outperforming peers as traders targeted the micro-float stock during a policy-driven sector rebound.<a href="https://stocktwits.com/symbol/AKAN">AKAN stock</a> outperformed cannabis peers, including&nbsp;<a href="https://stocktwits.com/symbol/TCNNF">Trulieve Cannabis (TCNNF)</a>, up 94%;&nbsp;<a href="https://stocktwits.com/symbol/CGC">Canopy Growth Corp. (CGC)</a>, up 30%;&nbsp;<a href="https://stocktwits.com/symbol/IGC">IGC Pharma (IGC)</a>, up 25%; and&nbsp;<a href="https://stocktwits.com/symbol/ACB">Aurora Cannabis (ACB)</a>, up 12%, over the past month. AKAN is also poised to log its best week ever,&nbsp;having more than quadrupled as of Thursday’s close.&nbsp;<img src="https://news.stocktwits-cdn.com/koyfin_20260501_083616528_png_777b15d360.webp" alt="koyfin_20260501_083616528.png"><h2 class="st-heading-2">Tiny Float, Higher Buzz For AKAN</h2>Investor sentiment for cannabis stocks got a boost after the U.S. government moved state-regulated marijuana from Schedule I toward Schedule III, pushing increased medical research access, tax treatment clarity, and regulatory legitimacy.The change revived optimism across the medical cannabis sector, with traders rotating into smaller stocks, which have exposure to future regulatory tailwinds. Akanda had previously welcomed U.S. rescheduling efforts in December, keeping the company relevant in the segment.The company operates a hemp platform focused on expanding access to medicinal-grade cannabis, CBD, and wellness products across legal markets. THC, or tetrahydrocannabinol, is the part of cannabis that produces the “high” and is therefore more tightly regulated, while CBD, or cannabidiol, does not cause intoxication and is widely used in medical and wellness treatments.&nbsp;The company implemented a 1-for-3.125 reverse stock split last year, followed by a more recent 1-for-5 reverse stock split in January. A further reverse split adjustment last month reduced its total float to 534,420 shares. Short levels for the stock currently stand at 4.7%, its highest levels in four months.&nbsp;Meanwhile, cannabis peers such as TLRY have a float of 119.28 million shares, CGC about 380.82 million, and CRON nearly 379.05 million. The comparatively tiny supply made AKAN shares more sensitive to buying pressure amid April’s cannabis rally.<h2 class="st-heading-2">Canada Cultivation Plans Take Root</h2>Akanda’s main cannabis asset is its Gabriola Island cultivation site in British Columbia, where the company currently operates under a hemp cultivation license, while working toward a full THC cultivation license covering cannabis flower and derivative products. In October, the company extended its option on the property for an additional two years.The pot firm has also been evaluating Health Canada-aligned security infrastructure requirements, including improved perimeter controls, surveillance systems, access management, and secure storage measures needed in licensing inspections for THC and CBD activities. Commercial THC production has not yet begun at the site.Akanda also exited its earlier African cultivation exposure after operations at its former unit in Lesotho ceased following an unauthorized liquidation ordered by the High Court of Lesotho in 2022, after which Akanda moved away from the region. It later discontinued operations at its Canmart distribution unit in the UK last year, citing licensing renewal costs and litigation exposure that outweighed expected near-term revenues.<h2 class="st-heading-2">Telecom Pivot Adds A Safety Net</h2>Akanda has also been gradually refocusing its strategy more heavily on Canada and Europe, while building a parallel telecommunications infrastructure platform through its unit, First Towers &amp; Fiber, in Mexico.&nbsp;As part of the pivot, the company has been expanding its dark-fiber network footprint across Central Mexico, including a recent addition of about 200 kilometers of infrastructure, which is expected to generate $2 million in contracted cash flow over 10 years. The move into telecom has added a source of contract-based income alongside Akanda’s medical cannabis business, providing investors with a potential hedge against the typical volatility in pure-cannabis companies.&nbsp;<h2 class="st-heading-2">How Do Retail Traders Feel About AKAN?</h2>On Stocktwits, retail sentiment for AKAN was ‘extremely bullish’ amid an eye-watering 231,800% surge in message volumes over the past month.<figure class="image"><img src="https://news.stocktwits-cdn.com/akan_ss_png_05e51e83c2.webp" alt="akan ss.png" width="974" height="140"><figcaption>AKAN sentiment and message volume as of April 30 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Stinkypoopypants/message/651947797">said</a>, “This is a low float that can run as high as it’s pushed. Shorts will have to cover at some point. Yes it will go down but the real question is how high can we push it?”<stembedurl>https://stocktwits.com/Stinkypoopypants/message/651947797</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/_MarginOfSanity_/message/651968893">said</a>, “Fundamentals don’t matter in a short squeeze. It’s just math. Limited supply meets infinite demand.”<stembedurl>https://stocktwits.com/_MarginOfSanity_/message/651968893</stembedurl>AKAN stock has jumped 376% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/asts-rklb-fly-lunr-stocks-rally-fcc-satellite-broadband-spectrum-rule/cZQNqL1ReIK">ASTS, RKLB, FLY, LUNR Stocks Rally As FCC Opens Door To Faster Satellite Broadband Networks</a>

AKAN stock has jumped 376% over the past year. Photo credit: Getty Images

AKAN Stock Leaves Cannabis Peers In The Smoke With A Stunning 1,700% Rally In April — What’s Fueling The Run?

The company’s primary cannabis asset remains its Gabriola Island cultivation site in British Columbia, where it operates under a hemp license.

Equity

<ul class="summary-bullets"><li>Since the marijuana reclassification move, AKAN stock has significantly outperformed peers Tilray, Canopy Growth, and Aurora Cannabis.</li><li>The regulatory shift on marijuana is expected to provide tax relief for licensed operators and support research.</li><li>AKAN stock is set to test the 200-DMA for the first time since October 2025.</li></ul>Shares of Akanda Corp (AKAN) are once again on a tear, surging 32% in pre-market trading on Thursday, yet even that sharp move would rank only as its fourth-biggest single-day gain this year if it holds at close.The latest pre-market jump extends a powerful two-day rally that has sent AKAN shares soaring about 114%, putting the stock on track to test its 200-day moving average for the first time since Oct. 1, 2025.<a href="https://stocktwits.com/symbol/AKAN">AKAN shares</a> recorded their best-ever single-day gains after news of marijuana reclassification broke earlier this month.&nbsp;The stock has rallied nearly 700% in the six sessions since then through Wednesday’s close.<h2 class="st-heading-2">What Triggered The Breakout Rally?</h2>The U.S. Department of Justice moved to <a href="https://stocktwits.com/news-articles/markets/equity/tlry-cgc-acb-msos-pare-early-gains-after-marijuana-reclassification-retail-says-weed-industry-is-reborn/cZBfz1nReRK">reclassify</a> medical marijuana as a less dangerous drug, following an executive order from President Donald Trump. The change moves it from Schedule I to Schedule III under the Controlled Substances Act.While the change does not legalize marijuana, it is expected to ease regulations, provide tax relief for licensed operators, and support research. Officials said the update will also speed up rulemaking, expand access to medical treatments, and strengthen oversight of medical marijuana programs across the U.S.<h2 class="st-heading-2">What Are Retail Traders Saying?</h2>AKAN shares have been under the spotlight for a while, with message volumes on Stocktwits exceeding a massive 106,200% over a 30-day period. Retail sentiment has remained in the ‘extremely bullish’ territory over the time period.One user expects the stock to climb to triple digits. It is currently trading at $35.<stembedurl>https://stocktwits.com/momoneyinfla/message/651829518</stembedurl>Another user said the movement doesn’t seem like a “pump and dump” scheme.<stembedurl>https://stocktwits.com/Wowsuchboolish/message/651836014</stembedurl>Since the marijuana reclassification move, AKAN stock has significantly outperformed Tilray (TLRY), which has lost around 8%, Canopy Growth (CGC), down around 4%, and Aurora Cannabis (ACB), also down around 8%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

On Monday, Deutsche Bank said CAR’s downgrade to ‘Hold’ from ‘Buy' is "purely fundamental in nature"

AKAN Stock Surges 32% Pre-Market – But Still Trails Its Largest Single-Day Rally This Year

The DOJ reclassified marijuana from a Schedule I to a Schedule III drug last week.

This Cannabis Stock’s 700% Run In A Week Has Retail Traders Eyeing Triple Digits

Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets

Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets PR Newswire EDMONTON, AB, April 28, 2026 NASDAQ | TSX: ACBQ1 launches reinforce...

Top Cannabis Stocks To Follow Now - April 27th

Tilray Brands, Akanda, Canopy Growth, Quantum Biopharma, and Aurora Cannabis are the five Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Cannabis stocks are shares of companies with significant business activities tied to the cannabis plant including cultivation, p...

Aurora Cannabis (OTCMKTS:ACBFF) Trading Down 13.7% - Here's Why

Aurora Cannabis (OTCMKTS:ACBFF) Shares Down 13.7% - Should You Sell...

In this photo illustration, a Tilray Brands logo is seen displayed on a smartphone and in the background.

Tilray Stock Eyes Breakout Week: Trump’s Cannabis Order Opens Door To US Cancer Market Entry

Trump has also called on Congress to preserve access to full-spectrum CBD products and expand research.

Aurora Cannabis (TSE:ACB) Stock Price Down 5.5% - Here's Why

Aurora Cannabis (TSE:ACB) Shares Down 5.5% - Here's What Happened...

<ul class="summary-bullets"><li>The change does not legalize marijuana but reduces regulatory hurdles and offers tax relief for licensed operators.</li><li>Trump has earlier framed the move as a step toward supporting medical research, while clarifying that it does not legalize recreational use.</li><li>The DOJ is updating procedures to speed up the rulemaking process needed to move marijuana from Schedule I to Schedule III.</li></ul>Shares of Tilray (TLRY), Canopy Growth (CGC), Aurora Cannabis (ACB), and IGC Pharma Inc (IGC) remained in focus after the U.S. Department of Justice formally moved to reclassify state-licensed medical marijuana as a less dangerous drug, four months after President Donald Trump signed an executive order to shift it from Schedule I to Schedule III.After rallying in the previous session and gaining in pre-market trading on Thursday, the stocks fell in morning trade. At the time of writing, TLRY, CGC, ACB and IGC fell between 2-5%.&nbsp;Meanwhile, AdvisorShares Pure US Cannabis ETF (MSOS) fell 5.5%.<h2 class="st-heading-2">DOJ To Update Rulemaking Processes For Reclassification</h2>While the change does not legalize marijuana, it reduces regulatory hurdles, offers tax relief for licensed operators, and makes research easier. Schedule III drugs are considered to have a moderate to low risk of dependence. Trump has earlier framed the move as a step toward supporting medical research, while clarifying that it does not legalize recreational use.“This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information,”&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana">said</a> Todd Blanche, acting Attorney General, in a statement.Separately, the Justice Department said it is updating procedures to speed up the rulemaking process needed to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. The move is expected to expand access to medical treatments and support research, while also strengthening the legal framework for medical marijuana programs across dozens of U.S. states.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits for TLRY, CGC, ACB, and IGC turned ‘extremely bullish,’ amid ‘extremely high’ message volumes.One user said, “The weed industry is reborn.”<stembedurl>https://stocktwits.com/Lando_Calrissian/message/651131346</stembedurl>Another user said Tilray will be the “king in the U.S. cannabis market.”<stembedurl>https://stocktwits.com/Rumsen/message/651070434</stembedurl>Meanwhile, shares of nano-cap Akanda Corp. (AKAN)&nbsp;climbed 6% higher,&nbsp;extending a stunning 215% surge from the previous session, with investors and traders debating whether the explosive rally is driven by cannabis reclassification optimism or the stock’s low float.Message volumes on the Stocktwits platform for the stock surged by around 48,000% over a 24-hour period.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Legalized Marijuana In Canada (Photo by Lane Turner/The Boston Globe via Getty Images)

TLRY, CGC, ACB, MSOS Pare Early Gains After Marijuana Reclassification: Retail Says ‘Weed Industry Is Reborn’

The U.S. Department of Justice formally moved to reclassify state-licensed medical marijuana as a less dangerous drug, four months after President Donald Trump signed an executive order.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

ACB
Aurora Cannabis Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest ACB News

ACBAurora Cannabis Inc